- Raised $10M funding round, Jan 2019
- Raised $20M funding round, Nov 2013
- Raised $7M funding round, Jun 2009
About
Sensible Medical Innovations has developed the ReDS medical radar technology, which originated from the defense industrys see through walls technology. ReDS is designed to monitor and manage patients with fluid management problems, including patients living with heart failure (HF), taking diuretic medication, or recovering from an event related to coronary artery disease. ReDS is intended for use by qualified healthcare practitioners and by patients under the direction of a physician in hospitals, hospital-type facilities, and the home environment. In a pilot study, ReDS-guided HF management reduced the number of HF-related rehospitalizations by approximately 80%. The company is headquartered in Israel with commercial offices in the United States. In August 2015, Sensible Medicals noninvasive thoracic fluid status monitor was cleared for market in the United States.
Funding history · 5 rounds · $37.6M total
Q&A
- What is Sensible Medical Innovations' primary focus?
- Sensible Medical Innovations focuses on noninvasive lung fluid monitoring and management using its ReDS medical radar technology.
- When was Sensible Medical Innovations founded?
- Sensible Medical Innovations was founded in June 2007.
- How many employees does Sensible Medical Innovations have?
- Sensible Medical Innovations has 11-50 employees.
- What is the total amount of funding Sensible Medical Innovations has raised?
- Sensible Medical Innovations has raised a total of $37,561,000.
- Which investors participated in Sensible Medical Innovations' 2013 funding round?
- In November 2013, Sensible Medical Innovations received funding from Genesis Partners and SCP Vitalife.
- When did Sensible Medical Innovations receive its most recent funding?
- Sensible Medical Innovations received its most recent funding in September 2019, a grant from EU Horizon 2020.
- Where is Sensible Medical Innovations headquartered?
- Sensible Medical Innovations is headquartered in Netanya, Israel, with commercial offices in Tenafly, New Jersey, USA.
- What is the core technology developed by Sensible Medical Innovations?
- Sensible Medical Innovations developed the ReDS medical radar technology, which originated from defense industry 'see-through-walls' technology.
- When was Sensible Medical Innovations' noninvasive thoracic fluid status monitor cleared for market in the United States?
- Sensible Medical Innovations' noninvasive thoracic fluid status monitor was cleared for market in the United States in August 2015.
Team · 5
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sensible-medical.com |
|---|---|
| linkedin.com/company/1079315 | |
| facebook.com/sensiblemedicalltd | |
| YouTube | youtube.com/channel/UCeTy3Ifw980KCHd5_hcnKEQ |
Identifiers & details
| Founded | 2007-6 |
|---|---|
| Employees (exact) | 36 |
| Offices | Tenafly |
Radar intelligence
Patents
| EPO | 23 |
|---|
Web history (Wayback)
| Domain | sensible-medical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|